A genetic screen identifies Tor as an interactor of VAPB in a Drosophila model of amyotrophic lateral sclerosis
Senthilkumar Deivasigamani, Hemant Kumar Verma, Ryu Ueda, Anuradha Ratnaparkhi, Girish S Ratnaparkhi, Senthilkumar Deivasigamani, Hemant Kumar Verma, Ryu Ueda, Anuradha Ratnaparkhi, Girish S Ratnaparkhi
Abstract
Amyotrophic Lateral Sclerosis (ALS) is a progressive neurodegenerative disorder characterized by selective death of motor neurons. In 5-10% of the familial cases, the disease is inherited because of mutations. One such mutation, P56S, was identified in human VAPB that behaves in a dominant negative manner, sequestering wild type protein into cytoplasmic inclusions. We have conducted a reverse genetic screen to identify interactors of Drosophila VAPB. We screened 2635 genes and identified 103 interactors, of which 45 were enhancers and 58 were suppressors of VAPB function. Interestingly, the screen identified known ALS loci - TBPH, alsin2 and SOD1. Also identified were genes involved in cellular energetics and homeostasis which were used to build a gene regulatory network of VAPB modifiers. One key modifier identified was Tor, whose knockdown reversed the large bouton phenotype associated with VAP(P58S) expression in neurons. A similar reversal was seen by over-expressing Tuberous Sclerosis Complex (Tsc1,2) that negatively regulates TOR signaling as also by reduction of S6K activity. In comparison, the small bouton phenotype associated with VAP(wt) expression was reversed with Tsc1 knock down as well as S6K-CA expression. Tor therefore interacts with both VAP(wt) and VAP(P58S), but in a contrasting manner. Reversal of VAP(P58S) bouton phenotypes in larvae fed with the TOR inhibitor Rapamycin suggests upregulation of TOR signaling in response to VAP(P58S) expression. The VAPB network and further mechanistic understanding of interactions with key pathways, such as the TOR cassette, will pave the way for a better understanding of the mechanisms of onset and progression of motor neuron disease.
Keywords: ALS; Drosophila RNAi screen; Neurodegeneration; TOR; VAP.
Conflict of interest statement
Competing interests: The authors have declared that no conflict of interest exists.
© 2014. Published by The Company of Biologists Ltd.
Figures
References
- Aliaga L., Lai C., Yu J., Chub N., Shim H., Sun L., Xie C., Yang W. J., Lin X., O'Donovan M. J. et al. (2013). Amyotrophic lateral sclerosis-related VAPB P56S mutation differentially affects the function and survival of corticospinal and spinal motor neurons. Hum. Mol. Genet. 22, 4293–4305 10.1093/hmg/ddt279
- Amarilio R., Ramachandran S., Sabanay H., Lev S. (2005). Differential regulation of endoplasmic reticulum structure through VAP-Nir protein interaction. J. Biol. Chem. 280, 5934–5944 10.1074/jbc.M409566200
- Ambegaokar S. S., Jackson G. R. (2011). Functional genomic screen and network analysis reveal novel modifiers of tauopathy dissociated from tau phosphorylation. Hum. Mol. Genet. 20, 4947–4977 10.1093/hmg/ddr432
- Andersen P. M., Al-Chalabi A. (2011). Clinical genetics of amyotrophic lateral sclerosis: what do we really know? Nat Rev Neurol 7, 603–615 10.1038/nrneurol.2011.150
- Caccamo A., Majumder S., Deng J. J., Bai Y., Thornton F. B., Oddo S. (2009). Rapamycin rescues TDP-43 mislocalization and the associated low molecular mass neurofilament instability. J. Biol. Chem. 284, 27416–27424 10.1074/jbc.M109.031278
- Caccamo A., Majumder S., Richardson A., Strong R., Oddo S. (2010). Molecular interplay between mammalian target of rapamycin (mTOR), amyloid-beta, and Tau: effects on cognitive impairments. J. Biol. Chem. 285, 13107–13120 10.1074/jbc.M110.100420
- Chen X., Burgoyne R. D. (2012). Identification of common genetic modifiers of neurodegenerative diseases from an integrative analysis of diverse genetic screens in model organisms. BMC Genomics 13, 71 10.1186/1471-2164-13-71
- Chen H. J., Anagnostou G., Chai A., Withers J., Morris A., Adhikaree J., Pennetta G., de Belleroche J. S. (2010). Characterization of the properties of a novel mutation in VAPB in familial amyotrophic lateral sclerosis. J. Biol. Chem. 285, 40266–40281 10.1074/jbc.M110.161398
- Cheng L., Locke C., Davis G. W. (2011). S6 kinase localizes to the presynaptic active zone and functions with PDK1 to control synapse development. J. Cell Biol. 194, 921–935 10.1083/jcb.201101042
- Ching J. K., Elizabeth S. V., Ju J. S., Lusk C., Pittman S. K., Weihl C. C. (2013). mTOR dysfunction contributes to vacuolar pathology and weakness in valosin-containing protein associated inclusion body myopathy. Hum. Mol. Genet. 22, 1167–1179 10.1093/hmg/dds524
- Christianson J. C., Olzmann J. A., Shaler T. A., Sowa M. E., Bennett E. J., Richter C. M., Tyler R. E., Greenblatt E. J., Harper J. W., Kopito R. R. (2012). Defining human ERAD networks through an integrative mapping strategy. Nat. Cell Biol. 14, 93–105 10.1038/ncb2383
- Costanzo M., Baryshnikova A., Bellay J., Kim Y., Spear E. D., Sevier C. S., Ding H., Koh J. L., Toufighi K., Mostafavi S. et al. (2010). The genetic landscape of a cell. Science 327, 425–431 10.1126/science.1180823
- De Vos K. J., Mórotz G. M., Stoica R., Tudor E. L., Lau K. F., Ackerley S., Warley A., Shaw C. E., Miller C. C. (2012). VAPB interacts with the mitochondrial protein PTPIP51 to regulate calcium homeostasis. Hum. Mol. Genet. 21, 1299–1311 10.1093/hmg/ddr559
- Dormann D., Rodde R., Edbauer D., Bentmann E., Fischer I., Hruscha A., Than M. E., Mackenzie I. R., Capell A., Schmid B. et al. (2010). ALS-associated fused in sarcoma (FUS) mutations disrupt Transportin-mediated nuclear import. EMBO J. 29, 2841–2857 10.1038/emboj.2010.143
- Floto R. A., Sarkar S., Perlstein E. O., Kampmann B., Schreiber S. L., Rubinsztein D. C. (2007). Small molecule enhancers of rapamycin-induced TOR inhibition promote autophagy, reduce toxicity in Huntington's disease models and enhance killing of mycobacteria by macrophages. Autophagy 3, 620–622 10.4161/auto.4898
- Franceschini A., Szklarczyk D., Frankild S., Kuhn M., Simonovic M., Roth A., Lin J., Minguez P., Bork P., von Mering C. et al. (2013). STRING v9.1: protein-protein interaction networks, with increased coverage and integration. Nucleic Acids Res. 41, D808–D815 10.1093/nar/gks1094
- Gkogkas C., Middleton S., Kremer A. M., Wardrope C., Hannah M., Gillingwater T. H., Skehel P. (2008). VAPB interacts with and modulates the activity of ATF6. Hum. Mol. Genet. 17, 1517–1526 10.1093/hmg/ddn040
- Guruharsha K. G., Rual J. F., Zhai B., Mintseris J., Vaidya P., Vaidya N., Beekman C., Wong C., Rhee D. Y., Cenaj O. et al. (2011). A protein complex network of Drosophila melanogaster. Cell 147, 690–703 10.1016/j.cell.2011.08.047
- Han S. M., Tsuda H., Yang Y., Vibbert J., Cottee P., Lee S. J., Winek J., Haueter C., Bellen H. J., Miller M. A. (2012). Secreted VAPB/ALS8 major sperm protein domains modulate mitochondrial localization and morphology via growth cone guidance receptors. Dev. Cell 22, 348–362 10.1016/j.devcel.2011.12.009
- Han J., Back S. H., Hur J., Lin Y. H., Gildersleeve R., Shan J., Yuan C. L., Krokowski D., Wang S., Hatzoglou M. et al. (2013a). ER-stress-induced transcriptional regulation increases protein synthesis leading to cell death. Nat. Cell Biol. 15, 481–490 10.1038/ncb2738
- Han J. H., Yu T. H., Ryu H. H., Jun M. H., Ban B. K., Jang D. J., Lee J. A. (2013b). ALS/FTLD-linked TDP-43 regulates neurite morphology and cell survival in differentiated neurons. Exp. Cell Res. 319, 1998–2005 10.1016/j.yexcr.2013.05.025
- Harris T. E., Lawrence J. C., Jr (2003). TOR signaling. Sci. STKE 2003, re15 10.1126/stke.2122003re15
- Hartai Z., Klivenyi P., Janaky T., Penke B., Dux L., Vecsei L. (2005). Kynurenine metabolism in plasma and in red blood cells in Parkinson's disease. J. Neurol. Sci. 239, 31–35 10.1016/j.jns.2005.07.006
- Heitman J., Movva N. R., Hall M. N. (1991). Targets for cell cycle arrest by the immunosuppressant rapamycin in yeast. Science 253, 905–909 10.1126/science.1715094
- Hoeffer C. A., Klann E. (2010). mTOR signaling: at the crossroads of plasticity, memory and disease. Trends Neurosci. 33, 67–75 10.1016/j.tins.2009.11.003
- Hu Y., Flockhart I., Vinayagam A., Bergwitz C., Berger B., Perrimon N., Mohr S. E. (2011). An integrative approach to ortholog prediction for disease-focused and other functional studies. BMC Bioinformatics 12, 357 10.1186/1471-2105-12-357
- Huang D. W., Sherman B. T., Lempicki R. A. (2009). Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat. Protoc. 4, 44–57 10.1038/nprot.2008.211
- Johnson S. C., Rabinovitch P. S., Kaeberlein M. (2013). mTOR is a key modulator of ageing and age-related disease. Nature 493, 338–345 10.1038/nature11861
- Kabashi E., El Oussini H., Bercier V., Gros-Louis F., Valdmanis P. N., McDearmid J., Mejier I. A., Dion P. A., Dupre N., Hollinger D. et al. (2013). Investigating the contribution of VAPB/ALS8 loss of function in amyotrophic lateral sclerosis. Hum. Mol. Genet. 22, 2350–2360 10.1093/hmg/ddt080
- Kaltenbach L. S., Romero E., Becklin R. R., Chettier R., Bell R., Phansalkar A., Strand A., Torcassi C., Savage J., Hurlburt A. et al. (2007). Huntingtin interacting proteins are genetic modifiers of neurodegeneration. PLoS Genet. 3, e82 10.1371/journal.pgen.0030082
- Kambris Z., Brun S., Jang I. H., Nam H. J., Romeo Y., Takahashi K., Lee W. J., Ueda R., Lemaitre B. (2006). Drosophila immunity: a large-scale in vivo RNAi screen identifies five serine proteases required for Toll activation. Curr. Biol. 16, 808–813 10.1016/j.cub.2006.03.020
- Laplante M., Sabatini D. M. (2012). mTOR signaling in growth control and disease. Cell 149, 274–293 10.1016/j.cell.2012.03.017
- Lev S., Ben Halevy D., Peretti D., Dahan N. (2008). The VAP protein family: from cellular functions to motor neuron disease. Trends Cell Biol. 18, 282–290 10.1016/j.tcb.2008.03.006
- Lin A., Wang R. T., Ahn S., Park C. C., Smith D. J. (2010). A genome-wide map of human genetic interactions inferred from radiation hybrid genotypes. Genome Res. 20, 1122–1132 10.1101/gr.104216.109
- Liu S., Lu B. (2010). Reduction of protein translation and activation of autophagy protect against PINK1 pathogenesis in Drosophila melanogaster. PLoS Genet. 6, e1001237 10.1371/journal.pgen.1001237
- Malagelada C., Jin Z. H., Jackson-Lewis V., Przedborski S., Greene L. A. (2010). Rapamycin protects against neuron death in in vitro and in vivo models of Parkinson's disease. J. Neurosci. 30, 1166–1175 10.1523/JNEUROSCI.3944-09.2010
- Marygold S. J., Leyland P. C., Seal R. L., Goodman J. L., Thurmond J., Strelets V. B., Wilson R. J. FlyBase consortium(2013). FlyBase: improvements to the bibliography. Nucleic Acids Res. 41, D751–D757 10.1093/nar/gks1024
- Mitne-Neto M., Ramos C. R., Pimenta D. C., Luz J. S., Nishimura A. L., Gonzales F. A., Oliveira C. C., Zatz M. (2007). A mutation in human VAP-B–MSP domain, present in ALS patients, affects the interaction with other cellular proteins. Protein Expr. Purif. 55, 139–146 10.1016/j.pep.2007.04.007
- Mórotz G. M., De Vos K. J., Vagnoni A., Ackerley S., Shaw C. E., Miller C. C. (2012). Amyotrophic lateral sclerosis-associated mutant VAPBP56S perturbs calcium homeostasis to disrupt axonal transport of mitochondria. Hum. Mol. Genet. 21, 1979–1988 10.1093/hmg/dds011
- Mostafavi S., Ray D., Warde-Farley D., Grouios C., Morris Q. (2008). GeneMANIA: a real-time multiple association network integration algorithm for predicting gene function. Genome Biol. 9, Suppl. 1S4 10.1186/gb-2008-9-s1-s4
- Moustaqim-Barrette A., Lin Y. Q., Pradhan S., Neely G. G., Bellen H. J., Tsuda H. (2014). The amyotrophic lateral sclerosis 8 protein, VAP, is required for ER protein quality control. Hum. Mol. Genet. 23, 1975–1989 10.1093/hmg/ddt594
- Natarajan R., Trivedi-Vyas D., Wairkar Y. P. (2013). Tuberous sclerosis complex regulates Drosophila neuromuscular junction growth via the TORC2/Akt pathway. Hum. Mol. Genet. 22, 2010–2023 10.1093/hmg/ddt053
- Nikawa J., Murakami A., Esumi E., Hosaka K. (1995). Cloning and sequence of the SCS2 gene, which can suppress the defect of INO1 expression in an inositol auxotrophic mutant of Saccharomyces cerevisiae. J. Biochem. 118, 39–45.
- Nishimura Y., Hayashi M., Inada H., Tanaka T. (1999). Molecular cloning and characterization of mammalian homologues of vesicle-associated membrane protein-associated (VAMP-associated) proteins. Biochem. Biophys. Res. Commun. 254, 21–26 10.1006/bbrc.1998.9876
- Nishimura A. L., Mitne-Neto M., Silva H. C., Richieri-Costa A., Middleton S., Cascio D., Kok F., Oliveira J. R., Gillingwater T., Webb J. et al. (2004). A mutation in the vesicle-trafficking protein VAPB causes late-onset spinal muscular atrophy and amyotrophic lateral sclerosis. Am. J. Hum. Genet. 75, 822–831 10.1086/425287
- Nishimura A. L., Al-Chalabi A., Zatz M. (2005). A common founder for amyotrophic lateral sclerosis type 8 (ALS8) in the Brazilian population. Hum. Genet. 118, 499–500 10.1007/s00439-005-0031-y
- Pasinelli P., Brown R. H. (2006). Molecular biology of amyotrophic lateral sclerosis: insights from genetics. Nat. Rev. Neurosci. 7, 710–723 10.1038/nrn1971
- Pennetta G., Hiesinger P. R., Fabian-Fine R., Meinertzhagen I. A., Bellen H. J. (2002). Drosophila VAP-33A directs bouton formation at neuromuscular junctions in a dosage-dependent manner. Neuron 35, 291–306 10.1016/S0896-6273(02)00769-9
- Penney J., Tsurudome K., Liao E. H., Elazzouzi F., Livingstone M., Gonzalez M., Sonenberg N., Haghighi A. P. (2012). TOR is required for the retrograde regulation of synaptic homeostasis at the Drosophila neuromuscular junction. Neuron 74, 166–178 10.1016/j.neuron.2012.01.030
- Pennuto M., Tinelli E., Malaguti M., Del Carro U., D'Antonio M., Ron D., Quattrini A., Feltri M. L., Wrabetz L. (2008). Ablation of the UPR-mediator CHOP restores motor function and reduces demyelination in Charcot-Marie-Tooth 1B mice. Neuron 57, 393–405 10.1016/j.neuron.2007.12.021
- Peretti D., Dahan N., Shimoni E., Hirschberg K., Lev S. (2008). Coordinated lipid transfer between the endoplasmic reticulum and the Golgi complex requires the VAP proteins and is essential for Golgi-mediated transport. Mol. Biol. Cell 19, 3871–3884 10.1091/mbc.E08-05-0498
- Perry R. J., Ridgway N. D. (2006). Oxysterol-binding protein and vesicle-associated membrane protein-associated protein are required for sterol-dependent activation of the ceramide transport protein. Mol. Biol. Cell 17, 2604–2616 10.1091/mbc.E06-01-0060
- Prause J., Goswami A., Katona I., Roos A., Schnizler M., Bushuven E., Dreier A., Buchkremer S., Johann S., Beyer C. et al. (2013). Altered localization, abnormal modification and loss of function of Sigma receptor-1 in amyotrophic lateral sclerosis. Hum. Mol. Genet. 22, 1581–1600 10.1093/hmg/ddt008
- Rao M., Song W., Jiang A., Shyr Y., Lev S., Greenstein D., Brantley-Sieders D., Chen J. (2012). VAMP-associated protein B (VAPB) promotes breast tumor growth by modulation of Akt activity. PLoS ONE 7, e46281 10.1371/journal.pone.0046281
- Ratnaparkhi A., Lawless G. M., Schweizer F. E., Golshani P., Jackson G. R. (2008). A Drosophila model of ALS: human ALS-associated mutation in VAP33A suggests a dominant negative mechanism. PLoS ONE 3, e2334 10.1371/journal.pone.0002334
- Ravikumar B., Vacher C., Berger Z., Davies J. E., Luo S., Oroz L. G., Scaravilli F., Easton D. F., Duden R., O'Kane C. J. et al. (2004). Inhibition of mTOR induces autophagy and reduces toxicity of polyglutamine expansions in fly and mouse models of Huntington disease. Nat. Genet. 36, 585–595 10.1038/ng1362
- Sen A., Dimlich D. N., Guruharsha K. G., Kankel M. W., Hori K., Yokokura T., Brachat S., Richardson D., Loureiro J., Sivasankaran R. et al. (2013). Genetic circuitry of Survival motor neuron, the gene underlying spinal muscular atrophy. Proc. Natl. Acad. Sci. USA 110, E2371–E2380 10.1073/pnas.1301738110
- Shulman J. M., De Jager P. L. (2009). Evidence for a common pathway linking neurodegenerative diseases. Nat. Genet. 41, 1261–1262 10.1038/ng1209-1261
- Silva M. C., Fox S., Beam M., Thakkar H., Amaral M. D., Morimoto R. I. (2011). A genetic screening strategy identifies novel regulators of the proteostasis network. PLoS Genet. 7, e1002438 10.1371/journal.pgen.1002438
- Skehel P. A., Martin K. C., Kandel E. R., Bartsch D. (1995). A VAMP-binding protein from Aplysia required for neurotransmitter release. Science 269, 1580–1583 10.1126/science.7667638
- Skehel P. A., Fabian-Fine R., Kandel E. R. (2000). Mouse VAP33 is associated with the endoplasmic reticulum and microtubules. Proc. Natl. Acad. Sci. USA 97, 1101–1106 10.1073/pnas.97.3.1101
- Spilman P., Podlutskaya N., Hart M. J., Debnath J., Gorostiza O., Bredesen D., Richardson A., Strong R., Galvan V. (2010). Inhibition of mTOR by rapamycin abolishes cognitive deficits and reduces amyloid-beta levels in a mouse model of Alzheimer's disease. PLoS ONE 5, e9979 10.1371/journal.pone.0009979
- Teuling E., Ahmed S., Haasdijk E., Demmers J., Steinmetz M. O., Akhmanova A., Jaarsma D., Hoogenraad C. C. (2007). Motor neuron disease-associated mutant vesicle-associated membrane protein-associated protein (VAP) B recruits wild-type VAPs into endoplasmic reticulum-derived tubular aggregates. J. Neurosci. 27, 9801–9815 10.1523/JNEUROSCI.2661-07.2007
- Thorp E., Li G., Seimon T. A., Kuriakose G., Ron D., Tabas I. (2009). Reduced apoptosis and plaque necrosis in advanced atherosclerotic lesions of Apoe−/− and Ldlr−/− mice lacking CHOP. Cell Metab. 9, 474–481 10.1016/j.cmet.2009.03.003
- Tran D., Chalhoub A., Schooley A., Zhang W., Ngsee J. K. (2012). A mutation in VAPB that causes amyotrophic lateral sclerosis also causes a nuclear envelope defect. J. Cell Sci. 125, 2831–2836 10.1242/jcs.102111
- Tsuda H., Han S. M., Yang Y., Tong C., Lin Y. Q., Mohan K., Haueter C., Zoghbi A., Harati Y., Kwan J. et al. (2008). The amyotrophic lateral sclerosis 8 protein VAPB is cleaved, secreted, and acts as a ligand for Eph receptors. Cell 133, 963–977 10.1016/j.cell.2008.04.039
- Tudor E. L., Galtrey C. M., Perkinton M. S., Lau K. F., De Vos K. J., Mitchell J. C., Ackerley S., Hortobágyi T., Vámos E., Leigh P. N. et al. (2010). Amyotrophic lateral sclerosis mutant vesicle-associated membrane protein-associated protein-B transgenic mice develop TAR-DNA-binding protein-43 pathology. Neuroscience 167, 774–785 10.1016/j.neuroscience.2010.02.035
- van Blitterswijk M., Vlam L., van Es M. A., van der Pol W. L., Hennekam E. A., Dooijes D., Schelhaas H. J., van der Kooi A. J., de Visser M., Veldink J. H. et al. (2012). Genetic overlap between apparently sporadic motor neuron diseases. PLoS ONE 7, e48983 10.1371/journal.pone.0048983
- van Ham T. J., Thijssen K. I., Breitling R., Hofstra R. M., Plasterk R. H., Nollen E. A. (2008). C. elegans model identifies genetic modifiers of alpha-synuclein inclusion formation during aging. PLoS Genet. 4, e1000027 10.1371/journal.pgen.1000027
- Wang T., Lao U., Edgar B. A. (2009). TOR-mediated autophagy regulates cell death in Drosophila neurodegenerative disease. J. Cell Biol. 186, 703–711 10.1083/jcb.200904090
- Wijesekera L. C., Leigh P. N. (2009). Amyotrophic lateral sclerosis. Orphanet J. Rare Dis. 4, 3 10.1186/1750-1172-4-3
- Yang Z., Huh S. U., Drennan J. M., Kathuria H., Martinez J. S., Tsuda H., Hall M. C., Clemens J. C. (2012). Drosophila Vap-33 is required for axonal localization of Dscam isoforms. J. Neurosci. 32, 17241–17250 10.1523/JNEUROSCI.2834-12.2012
- Zhang S., Binari R., Zhou R., Perrimon N. (2010). A genomewide RNA interference screen for modifiers of aggregates formation by mutant Huntingtin in Drosophila. Genetics 184, 1165–1179 10.1534/genetics.109.112516
- Zhang X., Li L., Chen S., Yang D., Wang Y., Zhang X., Wang Z., Le W. (2011). Rapamycin treatment augments motor neuron degeneration in SOD1(G93A) mouse model of amyotrophic lateral sclerosis. Autophagy 7, 412–425 10.4161/auto.7.4.14541
- Zoncu R., Efeyan A., Sabatini D. M. (2011). mTOR: from growth signal integration to cancer, diabetes and ageing. Nat. Rev. Mol. Cell Biol. 12, 21–35 10.1038/nrm3025
Source: PubMed